Drug Type Small molecule drug |
Synonyms Carteolol, Carteolol hydrochloride (JP17/USP), ABBOTT-43326 + [13] |
Action antagonists |
Mechanism β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists), β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists), β3-adrenergic receptor antagonists(Beta-3 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Oct 1980), |
Regulation- |
Molecular FormulaC16H25ClN2O3 |
InChIKeyFYBXRCFPOTXTJF-UHFFFAOYSA-N |
CAS Registry51781-21-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00599 | Carteolol Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Glaucoma | China | 01 Jan 1995 | |
| Cataract | Japan | 15 Feb 1984 | |
| Ocular Hypertension | Japan | 15 Feb 1984 | |
| Angina Pectoris | Japan | 25 Oct 1980 | |
| Arrhythmias, Cardiac | Japan | 25 Oct 1980 | |
| Hypertension | Japan | 25 Oct 1980 |





